Infection Prevention in Practice (Dec 2023)

Re-purposed drive-through vaccination set-up for Mpox, New York Metropolitan Area

  • Marina Keller,
  • Vishnu Chaturvedi,
  • Rebecca Glassman,
  • Donald S. Chen,
  • Marc El-Khoury,
  • Mary Dundas,
  • Nicholas Feola,
  • Varghese Thankachen,
  • Marie Yezzo,
  • Keri Tone,
  • Justin Williams,
  • Renee Garrick

Journal volume & issue
Vol. 5, no. 4
p. 100316

Abstract

Read online

Summary: Background: This report details how one large medical center in the Metropolitan New York area re-purposed a drive-through COVID-19 vaccination structure to handle a surge in Mpox cases in July 2022.Methods/Results: Simultaneous to on-going COVID -19 vaccination and testing, Mpox vaccination was rolled out in the same drive through structure. More than 1,820 Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) vaccine dosages were delivered subcutaneously and then intradermally to 1,123 individuals through the open window of their vehicles, averaging 8–10 patients an hour. Five vaccine recipients suffered Mpox rash; there was no exposure among healthcare providers. Conclusion: Drive-through vaccination is an efficient model to be redeployed for future unexpected vaccine initiatives.

Keywords